Saffron for Depression: Better Than You Think

Saffron (Crocus sativus) is best known as an expensive cooking spice. It is far less known as one of the most clinically supported natural antidepressants. The randomized-trial evidence behind it outperforms most herbal remedies and stands up well against pharmaceutical antidepressants in mild-to-moderate depression. The gap between how strong the evidence is and how few people have heard of it is striking.

The clinical evidence

The Hausenblas et al. 2013 meta-analysis (Journal of Integrative Medicine, PMID 24299602) was the first to pool the early trial data: 5 placebo-controlled and active-controlled studies showing saffron extract significantly outperformed placebo and matched fluoxetine and imipramine. Larger and more recent reviews have built on it. Marx et al. 2019 (Nutrition Reviews, PMID 31504123) pooled 23 RCTs and found saffron beat placebo by a large effect size (Hedges’ g around −0.99 for depression scores) and matched standard antidepressants head-to-head. Saffron also caused fewer side effects than SSRIs or tricyclics. These effect sizes are bigger than those of most other “mood” supplements and similar in size to the effect SSRIs show over placebo.

How it might work

Saffron’s active compounds are safranal and crocin — the carotenoid pigments that give the spice its color and aroma. Lab studies suggest these compounds slow serotonin reuptake (similar to how SSRIs work), tone down NMDA-receptor activity, and lower oxidative stress in the brain. The multi-target action may help explain why a botanical can match single-mechanism drugs in head-to-head trials. Saffron has also been linked to higher brain-derived neurotrophic factor (BDNF), a protein associated with antidepressant response.

Dose and form

Clinical trials consistently use 30 mg/day of a saffron extract standardized to safranal — either 30 mg once daily or 15 mg twice daily. You can’t reach this dose from cooking: heat destroys most of the active compounds, and recipes use only a few threads. Standardized capsules are needed. Onset of effect in trials is usually 4–6 weeks, similar to prescription antidepressants.

Who it’s for

The current evidence supports saffron as a reasonable option for mild-to-moderate depression, especially for people who prefer a non-drug option, who had significant SSRI side effects (such as sexual dysfunction), or who can’t access psychiatric care. It is not a stand-alone treatment for severe depression, suicidal ideation, bipolar disorder, or psychosis. If you take an SSRI, MAOI, or other serotonergic medication, talk to your doctor before adding saffron — in theory, combining serotonergic agents could increase the risk of serotonin syndrome. Don’t stop a prescribed antidepressant without medical guidance.